CAS: 5397-03-5 - methyl hydrazinecarbodithioate
Formula:C2H6N2S2
InChI:InChI=1/C2H6N2S2/c1-6-2(5)4-3/h3H2,1H3,(H,4,5)
- Synonyms:
- Hydrazinecarbodithioic Acid, Methyl Ester
- Methyl Hydrazine Carbodithioate
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | methyldithiocarbazate REF: IN-DA00DK95CAS: 5397-03-5 | 95% | 48.00 €~264.00 € | Fri 27 Dec 24 |
 | Methyl hydrazinecarbodithioate REF: 54-OR31015CAS: 5397-03-5 | 95% (nmr) (Typical Value in Batch COA) | 32.00 €~257.00 € | Fri 27 Dec 24 |
 | Hydrazinecarbodithioic acid methyl ester REF: 10-F545777CAS: 5397-03-5 | 95.0% | To inquire | Fri 03 Jan 25 |
 | Methyl hydrazinecarbodithioate REF: 3D-FAA39703CAS: 5397-03-5 | Min. 95% | - - - | Discontinued product |
methyldithiocarbazate
CAS:5397-03-5
Formula:
C2H6N2S2
Purity:
95%
Color and Shape:
Solid
Molecular weight:
122.2124
Ref: IN-DA00DK95
| 1g | 51.00 € | ||
| 5g | 77.00 € | ||
| 25g | 155.00 € | ||
| 100mg | 48.00 € |
Estimated delivery in United States, on Friday 27 Dec 2024
Methyl hydrazinecarbodithioate
CAS:5397-03-5
Formula:
C2H6N2S2
Purity:
95% (nmr) (Typical Value in Batch COA)
Color and Shape:
white solid
Molecular weight:
122.21g/mol
Ref: 54-OR31015
| 1g | 63.00 € | ||
| 5g | 257.00 € | ||
| 250mg | 32.00 € |
Estimated delivery in United States, on Friday 27 Dec 2024
Hydrazinecarbodithioic acid methyl ester
CAS:5397-03-5
Purity:
95.0%
Molecular weight:
122.19999694824219
Ref: 10-F545777
| 1g | To inquire | ||
| 5g | To inquire |
Estimated delivery in United States, on Friday 3 Jan 2025
Methyl hydrazinecarbodithioate
CAS:5397-03-5
Methyl hydrazinecarbodithioate is an inhibitor of the enzyme dihydrofolate reductase that is used as a …
Formula:
C2H6N2S2
Purity:
Min. 95%
Molecular weight:
122.21 g/mol
Ref: 3D-FAA39703
| 1g | Discontinued | Request information | |
| 5g | Discontinued | Request information | |
| 10g | Discontinued | Request information | |
| 250mg | Discontinued | Request information | |
| 500mg | Discontinued | Request information | |
| 2500mg | Discontinued | Request information |
